BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23139324)

  • 1. Molecular biology. Epigenetic islands in a genetic ocean.
    Schübeler D
    Science; 2012 Nov; 338(6108):756-7. PubMed ID: 23139324
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic regulation of the gene encoding steroidogenic factor-1.
    Hoivik EA; Bjanesoy TE; Bakke M
    Mol Cell Endocrinol; 2013 May; 371(1-2):133-9. PubMed ID: 23313548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11).
    Inoue S; Oishi M
    Gene; 2005 Mar; 348():123-34. PubMed ID: 15777718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory.
    Murayama A; Sakura K; Nakama M; Yasuzawa-Tanaka K; Fujita E; Tateishi Y; Wang Y; Ushijima T; Baba T; Shibuya K; Shibuya A; Kawabe Y; Yanagisawa J
    EMBO J; 2006 Mar; 25(5):1081-92. PubMed ID: 16498406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology. Genetic events that shape the cancer epigenome.
    Ryan RJ; Bernstein BE
    Science; 2012 Jun; 336(6088):1513-4. PubMed ID: 22723401
    [No Abstract]   [Full Text] [Related]  

  • 7. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways to silencing unite.
    Hayes S
    Nat Cell Biol; 2006 Apr; 8(4):315. PubMed ID: 16607271
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of CpG methylation on DNA binding protein: molecular dynamics simulations of the homeodomain PITX2 bound to the methylated DNA.
    Yang SY; Yang XL; Yao LF; Wang HB; Sun CK
    J Mol Graph Model; 2011 Jun; 29(7):920-7. PubMed ID: 21498098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTCF, a candidate trans-acting factor for X-inactivation choice.
    Chao W; Huynh KD; Spencer RJ; Davidow LS; Lee JT
    Science; 2002 Jan; 295(5553):345-7. PubMed ID: 11743158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleosomes at active promoters: unforgettable loss.
    Henikoff S
    Cancer Cell; 2007 Nov; 12(5):407-9. PubMed ID: 17996642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A consensus DNA recognition motif for two KDWK transcription factors identifies flexible-length, CpG-methylation sensitive cognate binding sites in the majority of human promoters.
    Burnett E; Christensen J; Tattersall P
    J Mol Biol; 2001 Dec; 314(5):1029-39. PubMed ID: 11743720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation: the nuts and bolts of repression.
    Miranda TB; Jones PA
    J Cell Physiol; 2007 Nov; 213(2):384-90. PubMed ID: 17708532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
    Martinowich K; Hattori D; Wu H; Fouse S; He F; Hu Y; Fan G; Sun YE
    Science; 2003 Oct; 302(5646):890-3. PubMed ID: 14593184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DBCAT: database of CpG islands and analytical tools for identifying comprehensive methylation profiles in cancer cells.
    Kuo HC; Lin PY; Chung TC; Chao CM; Lai LC; Tsai MH; Chuang EY
    J Comput Biol; 2011 Aug; 18(8):1013-7. PubMed ID: 21214365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction.
    Takeshima H; Yamashita S; Shimazu T; Ushijima T
    Genomics; 2011 Sep; 98(3):182-8. PubMed ID: 21683780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors.
    Mancini DN; Singh SM; Archer TK; Rodenhiser DI
    Oncogene; 1999 Jul; 18(28):4108-19. PubMed ID: 10435592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics. Do X chromosomes set boundaries?
    Percec I; Bartolomei MS
    Science; 2002 Jan; 295(5553):287-8. PubMed ID: 11786631
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of the NLRC5 promoter in chicken: SNPs, regulatory elements and CpG islands.
    Guo XM; Liu XP; Chang GB; Xu L; Bi YL; Wang HZ; Zhang Y; Zhu PF; Wu Y; Chen GH
    Anim Genet; 2016 Oct; 47(5):579-87. PubMed ID: 27429394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.